Terns Pharmaceuticals Inc... (TERN)
4.50
-0.03 (-0.66%)
At close: Jan 28, 2025, 2:11 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | 1.00M | n/a | n/a | n/a |
| Cost of Revenue | 881.00K | 1.03M | 512.00K | 394.00K | 195.00K | 65.00K |
| Gross Profit | -881.00K | -1.03M | 488.00K | -394.00K | -195.00K | -65.00K |
| Operating Income | -102.56M | -62.03M | -49.86M | -37.02M | -70.20M | -18.45M |
| Interest Income | 12.90M | 2.11M | 170.00K | 55.00K | 1.20M | 332.00K |
| Pretax Income | -89.97M | -59.99M | -49.65M | -39.76M | -68.84M | -18.09M |
| Net Income | -90.21M | -60.34M | -50.16M | -40.57M | -68.82M | -17.71M |
| Selling & General & Admin | 39.06M | 22.41M | 19.55M | 9.00M | 8.66M | 3.90M |
| Research & Development | 63.50M | 39.62M | 31.31M | 28.03M | 61.53M | 14.55M |
| Other Expenses | n/a | -68.00K | 40.00K | -2.79M | 154.00K | 38.00K |
| Operating Expenses | 102.56M | 62.03M | 50.86M | 37.02M | 70.20M | 18.45M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 102.56M | 62.03M | 50.86M | 37.02M | 70.20M | 18.45M |
| Income Tax | 239.00K | 358.00K | 508.00K | 813.00K | -20.00K | -67.00K |
| Shares Outstanding (Basic) | 71.26M | 36.03M | 25.27M | 25.13M | 25.10M | 23.97M |
| Shares Outstanding (Diluted) | 71.26M | 36.03M | 25.27M | 25.13M | 25.10M | 23.97M |
| EPS (Basic) | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| EPS (Diluted) | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| EBITDA | -102.27M | -58.95M | -49.35M | -36.63M | -35.00M | -18.39M |
| Depreciation & Amortization | 292.00K | 1.03M | 512.00K | 394.00K | 195.00K | 65.00K |